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ORIGINAL RESEARCH • EVIDENCE-BASED PRACTICE
MRI has high sensitivity but lower specificity (93% and 71%, respectively) (1) for the depiction of 
breast lesions. To improve specificity, the diffusion 
properties of breast lesions have been investigated. The 
apparent diffusion coefficient (ADC), measured by us-
ing diffusion-weighted imaging (DWI), is increasingly 
used as a marker in the detection and characterization 
of breast lesions. The ADC of a malignant lesion is 
lower than that of a benign lesion because of the re-
stricted diffusion in regions of high cellular density, 
which is often the result of proliferation of glandular 
tissue. Multiple studies have set a threshold value for 
ADC and assessed the diagnostic utility in identify-
ing malignant and benign lesions. Advanced diffusion 
models attempt to capture more complex aspects of 
the tumor microenvironment, including diffusion 
anisotropy and deviation from the monoexponential 
model due to perfusion effects.
Diffusion-tensor imaging (DTI) is an extension of dif-
fusion MRI that considers the anisotropy and directionality 
of diffusion because of the effects of restrictions imposed by 
cell membranes and walls of microstructures. DTI measures 
orthogonal eigenvectors of diffusion and their eigenvalues, 
l1, l2, and l3, from which the mean diffusivity, maximal 
anisotropy index (l1–l3), and fractional anisotropy can be 
calculated. DTI has been used in the differential diagnosis 
of glioblastoma (2), renal cell carcinoma (3), and prostate 
cancer (4), and in the breast to depict cancer and track the 
mammary ductal network (5).
Intravoxel incoherent motion (IVIM) was introduced 
by Le Bihan et al (6) as a method of separating the ef-
fects of diffusion and perfusion by fitting a biexponential 
A Meta-analysis of the Diagnostic Performance of 
Diffusion MRI for Breast Lesion Characterization
Gabrielle C. Baxter, MPhys • Martin J. Graves, PhD • Fiona J. Gilbert, MD, FRCR, FRCP • Andrew J. Patterson, PhD
From the Department of Radiology, School of Clinical Medicine, University of Cambridge, Box 218, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, 
England (G.C.B., F.J.G.); and Department of Radiology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England (M.J.G., 
A.J.P.). Received October 30, 2018; revision requested December 11; revision received March 8, 2019; accepted March 13. Address correspondence to F.J.G. (e-mail: 
fjg28@medschl.cam.ac.uk).
Study sponsored by the National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service 
Foundation Trust). F.J.G. sponsored by the National Institute for Health Research Senior Investigator award. The views expressed are those of the authors and not neces-
sarily those of the National Health Service, the National Institute for Health Research, or the Department of Health and Social Care.
Conflicts of interest are listed at the end of this article.
Radiology 2019; 00:1–11 • https://doi.org/10.1148/radiol.2019182510 • Content code: 
Background: Various techniques are available to assess diffusion properties of breast lesions as a marker of malignancy at MRI. The 
diagnostic performance of these diffusion markers has not been comprehensively assessed.
Purpose: To compare by meta-analysis the diagnostic performance of parameters from diffusion-weighted imaging (DWI), 
diffusion-tensor imaging (DTI), and intravoxel incoherent motion (IVIM) in the differential diagnosis of malignant and benign 
breast lesions.
Materials and Methods: PubMed and Embase databases were searched from January to March 2018 for studies in English that as-
sessed the diagnostic performance of DWI, DTI, and IVIM in the breast. Studies were reviewed according to eligibility and exclu-
sion criteria. Publication bias and heterogeneity between studies were assessed. Pooled summary estimates for sensitivity, specificity, 
and area under the curve were obtained for each parameter by using a bivariate model. A subanalysis investigated the effect of MRI 
parameters on diagnostic performance by using a Student t test or a one-way analysis of variance.
Results: From 73 eligible studies, 6791 lesions (3930 malignant and 2861 benign) were included. Publication bias was evident 
for studies that evaluated apparent diffusion coefficient (ADC). Significant heterogeneity (P , .05) was present for all parameters 
except the perfusion fraction (f ). The pooled sensitivity, specificity, and area under the curve for ADC was 89%, 82%, and 0.92, 
respectively. The highest performing parameter for DTI was the prime diffusion coefficient (l1), and pooled sensitivity, specificity, 
and area under the curve was 93%, 90%, and 0.94, respectively. The highest performing parameter for IVIM was tissue diffusivity 
(D), and the pooled sensitivity, specificity, and area under the curve was 88%, 79%, and 0.90. Choice of MRI parameters had no 
significant effect on diagnostic performance.
Conclusion: Diffusion-weighted imaging, diffusion-tensor imaging, and intravoxel incoherent motion have comparable diagnos-
tic accuracy with high sensitivity and specificity. Intravoxel incoherent motion is comparable to apparent diffusion coefficient. 
Diffusion-tensor imaging is potentially promising but to date the number of studies is limited.
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Study Selection
Studies were included if they met the following eligibility 
criteria: published in a peer-reviewed journal (abstracts and 
conference proceedings excluded); in English; data obtained 
by using a 1.5-T or 3.0-T MRI machine with MRI acquisi-
tion information reported; DWI performed and ADC, DTI, 
or IVIM parameters calculated; the purpose of the study was 
to investigate the diagnostic performance of ADC, DTI, or 
IVIM with criteria for classifying benign and malignant le-
sions clearly stated (ie, threshold value used for a parameter 
and a computational method used); and sufficient informa-
tion was reported to extract the number of true-positive, 
false-negative, false-positive, and true-negative findings clas-
sified by using the diagnostic criteria (if the values reported 
could not be reproduced, the study was excluded); and no 
limit was defined for age or sample size.
Data Extraction
A data extraction spreadsheet was developed. Data extraction 
was performed by one author (G.C.B.) and confirmed by a sec-
ond reviewer (A.J.P., with 12 years of experience). The number 
of true-positive, false-negative, false-positive, and true-negative 
findings by using parameters ADC, mean diffusivity, prime 
diffusion coefficient (l1), maximal anisotropy index (l1–l3), 
fractional anisotropy, D, f, and D* were extracted. For stud-
ies that reported multiple sensitivities and specificities, we ex-
tracted the method that achieved the highest number of cor-
rectly classified lesions (true-positive findings + true-negative 
findings) to avoid overrepresentation of a sample. For studies 
that used both a training set and a test set, we extracted the 
test set values. We extracted reader 1 when studies had mul-
tiple readers. For authors with multiple studies published in 
the same year, we extracted values from only one of the studies.
Other information extracted included the following: 
mean age and age range or standard deviation (whichever 
reported), study design, MRI machine and vendor, breast 
coil used, b values (sec/mm2), repetition time, echo time, 
matrix size, section thickness, field of view, parallel accelera-
tion (generalized autocalibrating parallel acceleration and 
sensitivity encoding, and acceleration factor), and fat sup-
pression method. We contacted corresponding authors for 
missing information.
Data Quality Assessment
The Quality Assessment of Diagnostic Accuracy Studies–2 was 
performed to assess the quality of studies and likelihood of bias 
(14). We assessed risk of bias in four domains: patient selection, 
method of the index test (parameter measurement and use of ap-
propriate threshold to classify lesions), use of histologic analysis 
as a reference standard, and flow and timing. We constructed 
funnel plots to visually examine publication bias. An asymmetric 
or skewed funnel plot suggested the presence of a publication 
bias. Asymmetry was quantified by using the Egger test (15), 
and a P value of less than .05 indicated publication bias. The 
degree of heterogeneity between studies was measured by Co-
chran Q test and Higgins I 2 test (16) by using Meta-Disc version 
1.4 (Clinical Biostatistics Unit, Hospital Ramon y Cajal, Ma-
Abbreviations
ADC = apparent diffusion coefficient, DTI = diffusion-tensor imag-
ing, DWI = diffusion-weighted imaging, IVIM = intravoxel incoherent 
motion
Summary
Diffusion-weighted imaging, diffusion-tensor imaging, and intravoxel 
incoherent motion have comparable diagnostic performance for iden-
tification of breast malignancy at MRI.
Key Points
 n Diffusion-weighted MRI for depicting malignant breast lesions 
has good sensitivity and specificity (89% and 82%, respectively), 
which is similar to that of dynamic contrast agent–enhanced MRI 
(93% and 71%, respectively).
 n Intravoxel incoherent motion MRI has high sensitivity and speci-
ficity (88% and 79%, respectively) to identify malignant versus 
benign breast lesions; diffusion-tensor imaging has slightly better 
diagnostic accuracy (sensitivity and specificity, 93% and 90%, 
respectively).
 n There is no evidence to suggest that choice of minimum b value 
improves diagnostic performance (ie, 0 or 50 sec/mm2).
model to the decay of signal by b value. In the IVIM model, 
tissue diffusivity is described by parameter D, pseudodiffusion 
or perfusion is the parameter D*, and the perfusion fraction is 
the parameter f. This approach has been used in the brain (7), 
head and neck (8), and prostate (9). It was first used in the 
breast by Sigmund et al (10) to measure the differences in con-
tribution of the microvasculature between malignant lesions 
and normal fibroglandular tissue.
Whereas previous meta-analyses have assessed the perfor-
mance of the ADC model in differentiating between benign and 
malignant lesions (11–13), more advanced diffusion techniques 
aim to improve on the results of quantitative DWI. Our meta-
analysis compares the diagnostic performance of these advanced 
diffusion techniques, including DWI, DTI, and IVIM to assess 
whether they achieve an improvement in diagnostic performance 
that justifies their higher computational complexity and longer 
imaging time, which are needed to acquire the range of b values 
or diffusion directions. Because of the lack of standardization 
in diffusion imaging, a subanalysis investigates how acquisition 
sequence variations affect diagnostic performance.
Materials and Methods
Literature Search
A search of PubMed and Embase was performed for studies 
that involved women older than 18 years between January 
2000 and March 2018 by one of the authors (G.C.B., with 
1 year of experience). The search terms for ADC studies in-
cluded breast, diffusion, apparent diffusion coefficient, ADC, 
and monoexponential. The search terms for DTI studies in-
cluded breast, diffusion tensor imaging, and DTI. The search 
terms for IVIM studies included breast, diffusion, intravoxel 
incoherent motion, IVIM, biexponential, and non-mono-ex-
ponential. A search of the lists of references from included 
studies was also performed.
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The effect of b value (minimum, 
maximum, and number used) and 
other MRI parameters such as field 
strength, vendor, use of partial field of 
view, section thickness, and resolution 
on diagnostic performance (sensitivity, 
specificity, and area under the receiver 
operating characteristic curve) was 
compared by using a Student t test, 
Mann-Whitney U test, or a one-way 
analysis of variance. Method of region-
of-interest delineation (use of the 
whole lesion, a small region of interest, 
or a single section) was also compared 
with diagnostic performance by us-
ing an analysis of variance. A P value 
less than .05 indicated a statistically 
significant difference. The data were 
analyzed in R (R Foundation for Sta-
tistical Computing).
Results
Study Selection and Data 
Extraction
By using the key words, a search of 
the PubMed and Embase databases 
returned 515 ADC studies, and 65 
of those met the eligibility criteria. 
A search for DTI returned 71 stud-
ies, and six of those met the eligibility 
criteria. A search for IVIM returned 
80 studies, and nine of those met the 
eligibility criteria. We excluded 413 
studies after a review of the titles and 
abstracts. We reviewed the full text 
of the remaining 253 studies and 
excluded 173 that did not meet the 
eligibility criteria. A total of 80 stud-
ies were included in the meta-analysis 
(5,18–89). Six studies evaluated both 
ADC and IVIM and one study evalu-
ated both ADC and DTI for all pa-
tients included in the study. Figure 1 
shows our flowchart of article exclusion. Details of included 
studies are provided in Table E1 (online). We included 6791 
lesions (3930 malignant and 2861 benign) from 73 eligible 
studies. There was a large range of reported mean ADC values 
of malignant (0.66–1.50 3 1023 mm2/sec) and benign lesions 
(0.87–2.00 3 1023 mm2/sec). Reported diagnostic threshold 
ADC values ranged from 0.87 3 1023 mm2/sec to 2 3 1023 
mm2/sec. A number of studies with DTI and IVIM used a 
combined-thresholds approach. The sensitivities and specifici-
ties of these studies are in Table 1. Jiang et al (90) reported a 
sensitivity and specificity for D* and f combined, whereas Bo-
kacheva et al (53) reported a combination of D and f by using 
linear discriminant analysis. Dijkstra et al (22) used all three 
drid, Spain, http://www.hrc.es/investigacion/metadisc_en.htm). A 
P value less than .05 for Cochran Q test or an I 2 value of greater 
than 50% indicated statistically significant heterogeneity.
Statistical Analysis
For each of the parameters (ADC; mean diffusivity; l1; l1–l3; 
fractional anisotropy; and D, f, and D*), we constructed forest 
plots for sensitivity and specificity. We used the bivariate model by 
Reitsma et al (17) to estimate pooled sensitivities, specificities, and 
areas under the curve for all parameters and construct summary 
receiver operating characteristic curves. Analysis was performed by 
using statistical software (R version 3.1.3; R Foundation for Sta-
tistical Computing, Vienna, Austria) by using the mada package.
Figure 1: Flowchart for selection and exclusion of studies. ADC = apparent diffusion coefficient, 
DTI = diffusion-tensor imaging, FN = false negative, FP = false positive, IVIM = intravoxel incoher-
ent motion, TN = true negative, TP = true positive.
Table 1: Combined Approaches by Using DTI and IVIM Parameters
Author Sensitivity (%) Specificity (%) Method
Jiang et al (90) 80.6 74.3 Combined thresholds D*, f
Iima et al (91) 94.7 75.0 Combined thresholds f, ADC, K
Jiang et al (27) 85.3 90.9 Combined thresholds FA and l1–l3
Dijkstra et al (22) 92.2 52.2 Combined thresholds D, D*, f
Bokacheva et al (53) 85.0 86.0 Linear discriminant analysis D, f
Note.—l1–l3 = maximal anisotropy index, ADC = apparent diffusion coefficient, D = tissue 
diffusivity coefficient, D* = pseudodiffusion coefficient, f = perfusion fraction coefficient, FA = 
fractional anisotropy, K = diffusion kurtosis coefficient.
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Data Quality Assessment
Figure 2 shows the distribution of Quality Assessment of 
Diagnostic Accuracy Studies–2 scores for risk of bias. The 
majority of studies had a low risk of bias. Some studies 
were marked as unclear concerning 
patient selection because of miss-
ing inclusion or exclusion criteria. 
Common weaknesses included the 
lack of justification for diagnostic 
threshold (n = 19), where receiver 
operating characteristic curves or 
other analyses were not used, or the 
lack of consistent use of histologic 
analysis as the reference standard 
for all patients (n = 11).
Figure 3 is a funnel plot of ADC 
studies and it has a funnel-shaped 
distribution; the lack of studies in the 
bottom left quadrant indicates publi-
cation bias. We measured significant 
asymmetry by using Egger test (P , 
.001). Because of the low number of 
Figure 3: Funnel plots for apparent diffusion coefficient (ADC), intravoxel incoherent motion (IVIM), and diffusion-tensor 
imaging (DTI) parameters. Log of diagnostic odds ratio (DOR) is plotted against standard error. The vertical line represents the 
median. IVIM parameters include tissue diffusivity (D), perfusion fraction (f ), and pseudodiffusion (D*). DTI parameters include 
mean diffusivity (MD), the prime diffusion coefficient (l1), the maximal anisotropy index (l1–l3), and the fractional anisotropy (FA).
Table 2: Results of Pooled Estimates and Heterogeneity Measures for Diffusion MRI Studies of the Breast
Parameter
No. of 
Studies
No. of  
Lesions* Sensitivity (%)
Heterogeneity
Specificity (%)
Heterogeneity
AUC
Cochran  
Q P Value I 2 (%)
Cochran  
Q P Value I 2 (%)
ADC 65 6408 (5892) 89 (87, 91) ,.001 71 82 (78, 85) ,.001 86 0.92 (0.91, 0.93)
D 7 536 (486) 88 (79, 92) .001 72 79 (64, 89) ,.001 81 0.90 (0.85, 0.96)
f 7 397 (366) 81 (74, 86) .34 12 76 (64, 85) .06 50 0.85 (0.81, 0.90)
D* 5 334 (309) 82 (67, 91) ,.001 87 61 (37, 80) ,.001 85 0.80 (0.74, 0.87)
l1 3 201 (181) 93 (80, 98) .10 56 90 (81, 95) .59 0 0.94 (0.91, 0.96)
MD 4 262 (247) 90 (79, 96) .03 66 78 (51, 92) .001 86 0.92 (0.90, 0.97)
l1-l3 3 201 (181) 73 (36, 93) ,.001 92 89 (62, 97) .004 82 0.89 (0.77, 1.00)
FA 3 219 (200) 64 (42, 81) .003 83 74 (62, 84) .61 0 0.76 (0.68, 0.87)
Note.—Unless otherwise indicated, data in parentheses are 95% confidence intervals. l1 = prime diffusion coefficient, l1–l3 = maximal 
anisotropy index, ADC = apparent diffusion coefficient, AUC = area under the receiver operating characteristic curve, D = tissue diffusivity, 
D* = pseudodiffusion coefficient, f = perfusion fraction, FA = fractional anisotropy, I2 = Higgin I2 test, MD = mean diffusivity.
* Data in parentheses are number of patients.
Figure 2: Results of quality assessment for risk of bias and concerns regarding applicability of 
included studies. Quality assessment of diagnostic accuracy studies (QUADAS-2) scores for each 
category are expressed by percentages of studies that have a low, high, or unclear risk of bias.
IVIM parameters and Iima et al (91) reported a combination 
of f, ADC, and diffusion kurtosis coefficient K. Jiang et al (27) 
also reported a combination of fractional anisotropy and the 
maximal anisotropy index.
Baxter et al
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studies for each of the other parameters, funnel asymmetry and 
Egger test were not assessed.
Statistical Analysis
Table 2 shows the results of the pooled analysis of ADC, DTI, 
and IVIM parameters. High heterogeneity between studies was 
Figure 4: Forest plots of sensitivity and specificity with 95% 
confidence intervals per study by using (a) apparent diffusion 
coefficient, (b) tissue diffusivity, and (c) prime diffusion coefficient. 
Vertical lines denote pooled summary estimates of sensitivity and 
specificity.
measured for most parameters except f. I 2 values of 0% were 
measured for the specificities of l1 and fractional anisotropy, 
however, the low number of studies included in the analysis 
(three studies for both) resulted in an undefined I 2 value versus 
significant lack of heterogeneity because Cochran P values were 
.59 and .61, respectively. The pooled area under the curve of 
the ADC was 0.92. The highest performing parameter for DTI 
was l1, with a pooled area under the curve of 0.94. The highest 
performing parameter for IVIM was D, with a pooled area under 
the curve of 0.90. Forest plots for sensitivity and specificity for 
all three parameters are in Figure 4. Summary receiver operating 
characteristic curves are in Figure 5. Examples of studies that 
used DTI and IVIM are shown in Figures 6 and 7, respectively.
Table 3 shows the results of the subanalysis. For studies 
that used ADC, choice of minimum b value of 0 sec/mm2 (n 
= 56) or 50 sec/mm2 (n = 9) had no significant effect on sen-
sitivity or specificity (P = .82 and P = .52, respectively). We 
found no significant differences (P . .05) in sensitivity and 
specificity for maximum b value, number of b values, field 
strength, vendor, partial field of view, section thickness, 
Diagnostic Performance of Diffusion MRI for Breast Lesion Characterization
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quantification depends on the choice of b values (92). A 
number of single-center studies have reported their optimal b 
value combination. Bogner et al (93) reported optimal ADC 
determination and DWI quality at b values of 50 and 850 
sec/mm2. Dorrius et al (94) indicated that b values of 0 and 
1000 sec/mm2 were optimum, and they found that this b 
value combination achieved the highest percentage difference 
in ADC of benign and malignant lesions. The b values 0 and 
1000 sec/mm2 were the most commonly used in our meta-
analysis (n = 29). It has been suggested that the use of more b 
values achieves a better separation of diffusion and perfusion 
(95), particularly at low b values where the contribution of 
perfusion to signal decay is strongest (6). Whereas this may 
suggest avoiding low b values, the precise b value threshold for 
minimizing perfusion effects has not been standardized and 
choice of minimum b value showed no significant difference 
in diagnostic performance in studies in our meta-analysis, 
though this may be because of the lack of statistical power. 
Also, the diagnostic accuracy of D, corresponding to an ADC 
measurement with effects of perfusion excluded, was compa-
rable to standard DWI. Whereas to our knowledge there is 
no consensus on whether excluding b value of 0 sec/mm2 or 
avoiding low b values constitutes excluding perfusion effects, 
both approaches have been shown to have limited effect on 
diagnostic performance. Choice of fat suppression technique 
spatial resolution, or 
method of region of in-
terest delineation.
Discussion
Whereas other meta-
analyses assessed the di-
agnostic performance 
of the apparent diffu-
sion coefficient (ADC) 
model (11–13), to our 
knowledge, ours is the 
first study to systemati-
cally compare all relevant 
advanced non-Gaussian 
diffusion techniques with 
standard diffusion-weighted imaging (DWI) for quantitatively 
distinguishing benign and malignant lesions. The pooled esti-
mates of sensitivity, specificity, and area under the receiver oper-
ating characteristic curve were found to be comparable for ADC, 
intravoxel incoherent motion (IVIM), and diffusion-tensor im-
aging (DTI). However, because of the small number of studies 
included and the large confidence intervals, this meta-analysis 
lacks the statistical power to conclude that they are diagnostically 
equivalent.
The pooled sensitivities and specificities of DWI, IVIM, and 
DTI in our meta-analysis were comparable to the pooled sensi-
tivity and specificity of dynamic contrast agent–enhanced MRI 
(93% and 71%, respectively) (1). Other non-Gaussian diffusion 
models have been proposed, such as diffusion kurtosis and the 
stretched exponential model, though these were not investigated 
because there have been few publications to date. A study by 
Suo et al (73) showed that kurtosis and stretched exponential 
achieved a better goodness-of-fit, although the areas under the 
receiver operating characteristic curve for nonmonoexponential 
models were comparable to the ADC, which was in accordance 
with our findings.
DTI lacks standardization in method and reporting 
of parameters. The prime diffusion direction (l1) and the 
mean diffusivity achieved a diagnostic accuracy equal to 
or greater than the ADC; however, the number of eligible 
studies included is low. Whereas it is suggested that reduced 
structuring in malignant breast lesions should be reflected 
by a reduced diffusion anisotropy (66), anisotropy measures 
achieved a mixed diagnostic utility; some studies find no 
significant difference in fractional anisotropy between ma-
lignant and benign lesions (40,57). The number of diffusion 
directions used ranged from six to 64, though use of the 
b value pair 0 and 1000 sec/mm2 was the most common 
(27,40,57,66).
Whereas the increasingly used technique of IVIM in 
the breast achieves a high diagnostic accuracy, there is also 
still a lack of consistent methods. There is a large variation 
in the number and range of b values used and in the choice 
of parameters reported, and studies often use a combined-
thresholds approach. Variations in MRI technique prevent 
determination of generalized threshold values because ADC 
Figure 5: Summary receiver operating characteristics (SROC) curves by using the bivariate model with 95% 
confidence regions. The pooled area under the curve was 0.92 for the apparent diffusion coefficient (ADC), 
0.90 for tissue diffusivity (D) and 0.94 for the prime diffusion coefficient (l1).
Table 3: Results of Subanalysis Comparing Studies by 
Using Apparent Diffusion Coefficient
Parameter
Sensitivity  
P Value
Specificity 
P Value
Minimum b value (0 or 50 sec/mm2) .82 .52
Maximum b value .08 .71
No. of b values .84 .94
Field strength (1.5 T or 3.0 T) .14 .64
Vendor .93 .78
Partial field of view .79 .43
Section thickness .60 .72
Spatial resolution .90 .65
Method of region-of-interest delineation .66 .57
Baxter et al
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Figure 6: Parametric diffusion maps of breast lesions. Lesions are indicated by arrows. The color-coded maps overlaid 
on the T2 image were processed with software (Matlab version 7.0.1; Mathworks, Natick, Mass). A–F, Invasive ductal car-
cinoma (37 mm, grade 2) and, G–L, fibroadenoma (20 mm). A, G, T2-weighted images of section at the center of the le-
sion showing anatomic features. Insert shows a vector map of n1 of the region marked by white square on the T2-weighted 
image. B, H, l1 maps of the same section as in A and G, respectively, overlaid on the corresponding T2-weighted image. 
C, I, Apparent diffusion coefficient (ADC) maps of the same section as in A and G, respectively, overlaid on the corre-
sponding T2-weighted image. D, J, Color-coded parametric maps of dynamic contrast-enhanced MRI analysis (three-time-
point method) of the same section as in A and G, respectively, overlaid on a T1-weighted image, show the color-coded 
contrast-enhanced region. The red pixels in the lesion indicate fast wash-in and fast wash-out, and the green pixels show 
fast wash-in followed by a plateau; both reflect cancer vascular properties. The blue pixels in the benign lesion indicate a 
delayed wash-out. E, K, l1-l3 map of the same section as in A and G, respectively, overlaid on the T2-weighted image. F, 
L, Fractional anisotropy maps of the same section as A and G, respectively, overlaid on the T2-weighted image. Reprinted, 
with permission, from reference 5.
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such as short-t inversion recovery or spectral adiabatic in-
version recovery has been shown to influence image quality 
and ADC quantification, although diagnostic performance 
was comparable (96). These discrepancies highlight the im-
portance of choosing similar protocols and methods of data 
analysis to compare studies across multiple centers.
Our meta-analysis had limitations. First, the low num-
ber of studies contributing to the pooled estimates resulted 
in large confidence intervals, which limited the conclusions 
that could be drawn from the comparable areas under the 
curve. Second, overrepresentation of a sample may be a limi-
tation of our pooled estimates because we included multiple 
studies from the same author that may have used the same 
patient population. Third, for studies that did not report 
true-positive, false-negative, false-positive, and true-nega-
tive findings, we calculated these outcomes from sensitivity, 
specificity, and number of malignant and benign lesions. 
However, many studies were excluded (n = 24) because they 
resulted in a noninteger number of lesions. Finally, because 
of the small numbers of publications, we did not include 
other nonmonoexponential models.
In conclusion, diffusion-weighted imaging, diffusion-
tensor imaging (DTI), and intravoxel incoherent motion 
(IVIM) were able to discriminate between malignant and 
benign lesions with a high sensitivity and specificity. IVIM 
was diagnostically comparable to apparent diffusion coeffi-
cient (ADC), although the exclusion of perfusion effects that 
used the tissue diffusion coefficient (D) did not improve on 
the results of the ADC model. DTI achieved a higher accu-
racy than did ADC, although the number of studies to date 
is limited. Both IVIM and DTI lack standardization in the 
reported methods and parameters.
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